Endometriosis Drugs Market Report

Global Endometriosis Drugs Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Apr 01, 2021
  • PAGES：168
  • REPORT CODE：GMM640687
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Endometriosis affects an estimated 1 in 10 women in the reproductive age group of 15-49 years.

    The Endometriosis Drugs is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period. The research provides insights for the global Endometriosis Drugs market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Endometriosis Drugs industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Endometriosis Drugs Market Segmentations:

    By Players:

    • ValiRx

    • Repros Therapeutics

    • Neurocrine Biosciences

    • Debiopharm Group

    • ObsEva

    • Evotec AG

    • AbbVie

    • Roivant Sciences GmbH

    • Pfizer

    • Kissei Pharmaceutical

    • Takeda Pharmaceutical Company Limited

    • AstraZeneca

    • Astellas Pharma

    By Types:

    • Hormonal Therapy

    • Add-back Medication

    • Progestogens

    • Chinese Herbs

    By End-User:

    • Hospitals

    • Clinics

    • Research Institutes

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Endometriosis Drugs Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Endometriosis Drugs Market Size and Growth Rate of Hormonal Therapy from 2014 to 2026

      • 1.3.2 Global Endometriosis Drugs Market Size and Growth Rate of Add-back Medication from 2014 to 2026

      • 1.3.3 Global Endometriosis Drugs Market Size and Growth Rate of Progestogens from 2014 to 2026

      • 1.3.4 Global Endometriosis Drugs Market Size and Growth Rate of Chinese Herbs from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Endometriosis Drugs Market Size and Growth Rate of Hospitals from 2014 to 2026

      • 1.4.2 Global Endometriosis Drugs Market Size and Growth Rate of Clinics from 2014 to 2026

      • 1.4.3 Global Endometriosis Drugs Market Size and Growth Rate of Research Institutes from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Endometriosis Drugs Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Endometriosis Drugs Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Endometriosis Drugs by Major Types

      • 3.4.1 Endometriosis Drugs Market Size and Growth Rate of Hormonal Therapy

      • 3.4.2 Endometriosis Drugs Market Size and Growth Rate of Add-back Medication

      • 3.4.3 Endometriosis Drugs Market Size and Growth Rate of Progestogens

      • 3.4.4 Endometriosis Drugs Market Size and Growth Rate of Chinese Herbs

    4 Segmentation of Endometriosis Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Endometriosis Drugs by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Endometriosis Drugs in Hospitals

      • 4.4.2 Market Size and Growth Rate of Endometriosis Drugs in Clinics

      • 4.4.3 Market Size and Growth Rate of Endometriosis Drugs in Research Institutes

    5 Market Analysis by Major Regions

    • 5.1 Global Endometriosis Drugs Production Analysis by Major Regions

    • 5.2 Global Endometriosis Drugs Consumption Analysis by Major Regions

    • 5.3 Global Endometriosis Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Endometriosis Drugs Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Endometriosis Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Endometriosis Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Endometriosis Drugs Production, Import, Consumption and Export Analysis

    6 Product Commodity of Endometriosis Drugs Market in Major Countries

    • 6.1 Top 5 Export Countries in Endometriosis Drugs market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Endometriosis Drugs market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Endometriosis Drugs market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Endometriosis Drugs market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Endometriosis Drugs market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Endometriosis Drugs market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Endometriosis Drugs Landscape Analysis

    • 7.1 North America Endometriosis Drugs Landscape Analysis by Major Types

    • 7.2 North America Endometriosis Drugs Landscape Analysis by Major End-Users

    • 7.3 North America Endometriosis Drugs Landscape Analysis by Major Countries

      • 7.3.1 United States Endometriosis Drugs Market Volume and Growth Rate

      • 7.3.2 Canada Endometriosis Drugs Market Volume and Growth Rate

      • 7.3.3 Mexico Endometriosis Drugs Market Volume and Growth Rate

    8 Europe Endometriosis Drugs Landscape Analysis

    • 8.1 Europe Endometriosis Drugs Landscape Analysis by Major Types

    • 8.2 Europe Endometriosis Drugs Landscape Analysis by Major End-Users

    • 8.3 Europe Endometriosis Drugs Landscape Analysis by Major Countries

      • 8.3.1 Germany Endometriosis Drugs Market Volume and Growth Rate

      • 8.3.2 UK Endometriosis Drugs Market Volume and Growth Rate

      • 8.3.3 France Endometriosis Drugs Market Volume and Growth Rate

      • 8.3.4 Italy Endometriosis Drugs Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Endometriosis Drugs Market Volume and Growth Rate

      • 8.3.6 Spain Endometriosis Drugs Market Volume and Growth Rate

      • 8.3.7 Belgium Endometriosis Drugs Market Volume and Growth Rate

      • 8.3.8 Poland Endometriosis Drugs Market Volume and Growth Rate

      • 8.3.9 Russia Endometriosis Drugs Market Volume and Growth Rate

      • 8.3.10 Turkey Endometriosis Drugs Market Volume and Growth Rate

    9 Asia Pacific Endometriosis Drugs Landscape Analysis

    • 9.1 Asia Pacific Endometriosis Drugs Landscape Analysis by Major Types

    • 9.2 Asia Pacific Endometriosis Drugs Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Endometriosis Drugs Landscape Analysis by Major Countries

      • 9.3.1 China Endometriosis Drugs Market Volume and Growth Rate

      • 9.3.2 Japan Endometriosis Drugs Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Endometriosis Drugs Market Volume and Growth Rate

      • 9.3.4 India Endometriosis Drugs Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Endometriosis Drugs Market Volume and Growth Rate

      • 9.3.6 South Korea Endometriosis Drugs Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Endometriosis Drugs Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Endometriosis Drugs Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Endometriosis Drugs Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Endometriosis Drugs Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Endometriosis Drugs Market Volume and Growth Rate

      • 10.3.2 Brazil Endometriosis Drugs Market Volume and Growth Rate

      • 10.3.3 Nigeria Endometriosis Drugs Market Volume and Growth Rate

      • 10.3.4 South Africa Endometriosis Drugs Market Volume and Growth Rate 

      • 10.3.5 Argentina Endometriosis Drugs Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 ValiRx

      • 11.1.1 ValiRx Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Repros Therapeutics

      • 11.2.1 Repros Therapeutics Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Neurocrine Biosciences

      • 11.3.1 Neurocrine Biosciences Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Debiopharm Group

      • 11.4.1 Debiopharm Group Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 ObsEva

      • 11.5.1 ObsEva Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Evotec AG

      • 11.6.1 Evotec AG Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 AbbVie

      • 11.7.1 AbbVie Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 Roivant Sciences GmbH

      • 11.8.1 Roivant Sciences GmbH Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Pfizer

      • 11.9.1 Pfizer Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Kissei Pharmaceutical

      • 11.10.1 Kissei Pharmaceutical Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 Takeda Pharmaceutical Company Limited

      • 11.11.1 Takeda Pharmaceutical Company Limited Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 AstraZeneca

      • 11.12.1 AstraZeneca Company Profile and Recent Development

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 Astellas Pharma

      • 11.13.1 Astellas Pharma Company Profile and Recent Development

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 92 Figures and 198 Tables)

    • Figure Product Picture

    • Figure Endometriosis Drugs Market Size and Growth Rate of Hormonal Therapy from 2014 to 2026

    • Figure Endometriosis Drugs Market Size and Growth Rate of Add-back Medication from 2014 to 2026

    • Figure Endometriosis Drugs Market Size and Growth Rate of Progestogens from 2014 to 2026

    • Figure Endometriosis Drugs Market Size and Growth Rate of Chinese Herbs from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Endometriosis Drugs Market Size and Growth Rate of Hospitals from 2014 to 2026

    • Figure Global Endometriosis Drugs Market Size and Growth Rate of Clinics from 2014 to 2026

    • Figure Global Endometriosis Drugs Market Size and Growth Rate of Research Institutes from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Endometriosis Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Endometriosis Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Endometriosis Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Endometriosis Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Endometriosis Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Hormonal Therapy

    • Figure Market Size and Growth Rate of Add-back Medication

    • Figure Market Size and Growth Rate of Progestogens

    • Figure Market Size and Growth Rate of Chinese Herbs

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Endometriosis Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Endometriosis Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospitals

    • Figure Market Size and Growth Rate of Clinics

    • Figure Market Size and Growth Rate of Research Institutes

    • Table Global Endometriosis Drugs Production by Major Regions

    • Table Global Endometriosis Drugs Production Share by Major Regions

    • Figure Global Endometriosis Drugs Production Share by Major Regions in 2014

    • Figure Global Endometriosis Drugs Production Share by Major Regions in 2018

    • Figure Global Endometriosis Drugs Production Share by Major Regions in 2026

    • Table Global Endometriosis Drugs Consumption by Major Regions

    • Table Global Endometriosis Drugs Consumption Share by Major Regions

    • Figure Global Endometriosis Drugs Consumption Share by Major Regions in 2014

    • Figure Global Endometriosis Drugs Consumption Share by Major Regions in 2018

    • Figure Global Endometriosis Drugs Consumption Share by Major Regions in 2026

    • Table North America Endometriosis Drugs Production, Import, Consumption and Export Analysis

    • Table Europe Endometriosis Drugs Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Endometriosis Drugs Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Endometriosis Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Endometriosis Drugs market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Endometriosis Drugs market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Endometriosis Drugs market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Endometriosis Drugs market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Endometriosis Drugs Consumption by Types from 2014 to 2026

    • Table North America Endometriosis Drugs Consumption Share by Types from 2014 to 2026

    • Figure North America Endometriosis Drugs Consumption Share by Types in 2014

    • Figure North America Endometriosis Drugs Consumption Share by Types in 2018

    • Figure North America Endometriosis Drugs Consumption Share by Types in 2026

    • Table North America Endometriosis Drugs Consumption by End-Users from 2014 to 2026

    • Table North America Endometriosis Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure North America Endometriosis Drugs Consumption Share by End-Users in 2014

    • Figure North America Endometriosis Drugs Consumption Share by End-Users in 2018

    • Figure North America Endometriosis Drugs Consumption Share by End-Users in 2026

    • Table North America Endometriosis Drugs Consumption by Major Countries from 2014 to 2026

    • Table North America Endometriosis Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Endometriosis Drugs Consumption Share by Major Countries in 2014

    • Figure North America Endometriosis Drugs Consumption Share by Major Countries in 2018

    • Figure North America Endometriosis Drugs Consumption Share by Major Countries in 2026

    • Figure United States Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Endometriosis Drugs Consumption by Types from 2014 to 2026

    • Table Europe Endometriosis Drugs Consumption Share by Types from 2014 to 2026

    • Figure Europe Endometriosis Drugs Consumption Share by Types in 2014

    • Figure Europe Endometriosis Drugs Consumption Share by Types in 2018

    • Figure Europe Endometriosis Drugs Consumption Share by Types in 2026

    • Table Europe Endometriosis Drugs Consumption by End-Users from 2014 to 2026

    • Table Europe Endometriosis Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Endometriosis Drugs Consumption Share by End-Users in 2014

    • Figure Europe Endometriosis Drugs Consumption Share by End-Users in 2018

    • Figure Europe Endometriosis Drugs Consumption Share by End-Users in 2026

    • Table Europe Endometriosis Drugs Consumption by Major Countries from 2014 to 2026

    • Table Europe Endometriosis Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Endometriosis Drugs Consumption Share by Major Countries in 2014

    • Figure Europe Endometriosis Drugs Consumption Share by Major Countries in 2018

    • Figure Europe Endometriosis Drugs Consumption Share by Major Countries in 2026

    • Figure Germany Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure France Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Endometriosis Drugs Consumption by Types from 2014 to 2026

    • Table Asia Pacific Endometriosis Drugs Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Endometriosis Drugs Consumption Share by Types in 2014

    • Figure Asia Pacific Endometriosis Drugs Consumption Share by Types in 2018

    • Figure Asia Pacific Endometriosis Drugs Consumption Share by Types in 2026

    • Table Asia Pacific Endometriosis Drugs Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Endometriosis Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Endometriosis Drugs Consumption Share by End-Users in 2014

    • Figure Asia Pacific Endometriosis Drugs Consumption Share by End-Users in 2018

    • Figure Asia Pacific Endometriosis Drugs Consumption Share by End-Users in 2026

    • Table Asia Pacific Endometriosis Drugs Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Endometriosis Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Endometriosis Drugs Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Endometriosis Drugs Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Endometriosis Drugs Consumption Share by Major Countries in 2026

    • Figure China Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandEndometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure India Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Endometriosis Drugs Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Endometriosis Drugs Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Endometriosis Drugs Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Endometriosis Drugs Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Endometriosis Drugs Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Endometriosis Drugs Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Endometriosis Drugs Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Endometriosis Drugs Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Endometriosis Drugs Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Endometriosis Drugs Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Endometriosis Drugs Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Endometriosis Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Endometriosis Drugs Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Endometriosis Drugs Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Endometriosis Drugs Consumption Share by Major Countries in 2026

    • Figure GCC Countries Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Endometriosis Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of ValiRx

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ValiRx

    • Figure Sales and Growth Rate Analysis of ValiRx

    • Figure Revenue and Market Share Analysis of ValiRx

    • Table Product and Service Introduction of ValiRx

    • Table Company Profile and Development Status of Repros Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Repros Therapeutics

    • Figure Sales and Growth Rate Analysis of Repros Therapeutics

    • Figure Revenue and Market Share Analysis of Repros Therapeutics

    • Table Product and Service Introduction of Repros Therapeutics

    • Table Company Profile and Development Status of Neurocrine Biosciences

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Neurocrine Biosciences

    • Figure Sales and Growth Rate Analysis of Neurocrine Biosciences

    • Figure Revenue and Market Share Analysis of Neurocrine Biosciences

    • Table Product and Service Introduction of Neurocrine Biosciences

    • Table Company Profile and Development Status of Debiopharm Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Debiopharm Group

    • Figure Sales and Growth Rate Analysis of Debiopharm Group

    • Figure Revenue and Market Share Analysis of Debiopharm Group

    • Table Product and Service Introduction of Debiopharm Group

    • Table Company Profile and Development Status of ObsEva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ObsEva

    • Figure Sales and Growth Rate Analysis of ObsEva

    • Figure Revenue and Market Share Analysis of ObsEva

    • Table Product and Service Introduction of ObsEva

    • Table Company Profile and Development Status of Evotec AG

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Evotec AG

    • Figure Sales and Growth Rate Analysis of Evotec AG

    • Figure Revenue and Market Share Analysis of Evotec AG

    • Table Product and Service Introduction of Evotec AG

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of Roivant Sciences GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roivant Sciences GmbH

    • Figure Sales and Growth Rate Analysis of Roivant Sciences GmbH

    • Figure Revenue and Market Share Analysis of Roivant Sciences GmbH

    • Table Product and Service Introduction of Roivant Sciences GmbH

    • Table Company Profile and Development Status of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Company Profile and Development Status of Kissei Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kissei Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Kissei Pharmaceutical

    • Figure Revenue and Market Share Analysis of Kissei Pharmaceutical

    • Table Product and Service Introduction of Kissei Pharmaceutical

    • Table Company Profile and Development Status of Takeda Pharmaceutical Company Limited

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceutical Company Limited

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceutical Company Limited

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceutical Company Limited

    • Table Product and Service Introduction of Takeda Pharmaceutical Company Limited

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of Astellas Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astellas Pharma

    • Figure Sales and Growth Rate Analysis of Astellas Pharma

    • Figure Revenue and Market Share Analysis of Astellas Pharma

    • Table Product and Service Introduction of Astellas Pharma


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US